Reports

Key Findings The chair of the House Ways and Means Committee has the authority to inspect the tax returns of any taxpayer, including the president, and may submit those tax returns to the full House for review, effectively making them public. The incoming House of Representatives should make it a top priority to obtain and […]

The November midterm election results in the U.S. House of Representatives were a clear rejection of President Trump’s tax and economic policies that favor the wealthy and corporations over working families. Prior to the November vote, pollsters for the Republican National Committee found that the GOP had “lost the messaging battle on the [tax] issue.” […]

READ FULL REPORT HERE In Congress, Rep. Rod Blum (R-IA) is an original cosponsor of a resolution declaring the national debt “a threat to national security.”  On her website, Rep. Mimi Walters (R-CA) says, “Our national debt is not only a threat to our financial security it is also a threat to our national security.” On his website, Rep. Erik […]

KEY FINDINGS “Republicans lost the messaging battle on the [tax] issue, per a Sept. 2 polling memo prepared for the Republican National Committee. Their poll found that by 61% to 30%, voters said the law benefits “large corporations and rich Americans” over “middle class families.” The memo attributed this to message discipline from the tax […]

Eight months since the tax cuts were passed in December 2017, here’s what the data show: Corporate profits up, corporate tax revenues down (Figure 1): In the second quarter of 2018 (six months after the tax cuts passed in December 2017), corporate after-tax profits were 16% higher than a year earlier in the second quarter […]

Our national and state-by-state reports about Medicare and Medicaid, in honor of its 53rd Anniversary. National Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York […]

View the Full Report in PDF here. INTRODUCTION & KEY FINDINGS America’s 10 biggest prescription-drug corporations—the Pharma Big 10—are among the biggest winners from the Trump-GOP tax cuts but they are sharing few of the benefits with their employees and are offering no pricing relief to their customers. Instead, they are mostly rewarding their CEOs […]

View the full report in PDF here. View state-by-state reports and graphics here. EXECUTIVE SUMMARY On Tax Day 2018, health care and other vital public services are much less secure for America’s working families due to $1.5 trillion in tax cuts enacted late last year by President Trump and the Republican Congress. The tax cuts […]

View the Full Report in PDF here. TOPLINES The report examines the profits, taxes, and drug prices of the 10 biggest U.S. pharmaceutical companies, the “Pharma Big 10”: Johnson & Johnson, Pfizer, Merck & Co., Gilead Sciences, AbbVie, Amgen, Eli Lilly & Co., Bristol-Myers Squibb, Biogen and Celgene. Between 2011 and 2015, the Pharma Big 10 […]

Support for the Affordable Care Act (ACA) is at its highest level ever. Yet, Republicans in Congress are determined to repeal Obamacare despite the public’s widespread opposition to their plan, known as the American Health Care Act. The GOP plan will deprive 24 million Americans of health care coverage and drive up the cost of coverage […]